A A Kirkwood
Overview
Explore the profile of A A Kirkwood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuhnl A, Roddie C, Kirkwood A, Chaganti S, Norman J, Lugthart S, et al.
Br J Haematol
. 2024 Apr;
205(2):483-494.
PMID: 38594876
Radiotherapy (RT) has potential synergistic effects with chimeric antigen receptor (CAR) T but is not widely used as bridging therapy due to logistical challenges and lack of standardised protocols. We...
2.
Kuhnl A, Kirkwood A, Roddie C, Menne T, Tholouli E, Bloor A, et al.
Br J Haematol
. 2023 Apr;
202(1):65-73.
PMID: 37082780
Large B-cell lymphoma (LBCL) patients with comorbidities and/or advanced age are increasingly considered for treatment with CD19 CAR T, but data on the clinical benefit of CAR T in the...
3.
McMillan A, Phillips E, Kirkwood A, Barrans S, Burton C, Rule S, et al.
Ann Oncol
. 2020 May;
31(9):1251-1259.
PMID: 32464282
Background: Outcomes for patients with high-risk diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP chemotherapy are suboptimal but, to date, no alternative regimen has been shown to improve survival rates....
4.
Patel B, Kirkwood A, Dey A, Marks D, McMillan A, Menne T, et al.
Leukemia
. 2016 Aug;
31(1):58-64.
PMID: 27480385
Safety and efficacy data on pegylated asparaginase (PEG-ASP) in adult acute lymphoblastic leukaemia (ALL) induction regimens are limited. The UK National Cancer Research Institute UKALL14 trial NCT01085617 prospectively evaluated the...
5.
Jenkinson S, Kirkwood A, Goulden N, Vora A, Linch D, Gale R
Leukemia
. 2015 Jul;
30(1):39-47.
PMID: 26220040
PTEN gene inactivation by mutation or deletion is common in pediatric T-cell acute lymphoblastic leukemia (T-ALL), but the impact on outcome is unclear, particularly in patients with NOTCH1/FBXW7 mutations. We...